# Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

> **NCT02208024** · NA · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 18 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT02208024
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-27
- **Primary completion:** 2017-10-11
- **Final completion:** 2019-05-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208024, "Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02208024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*